4//SEC Filing
Avgerinos George 4
Accession 0001144204-17-063792
CIK 0001429260other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 8:18 PM ET
Size
8.7 KB
Accession
0001144204-17-063792
Insider Transaction Report
Form 4
Avgerinos George
SVP, Biologics Operations
Transactions
- Sale
COMMON STOCK, PAR VALUE $0.001
2017-12-12$3.59/sh−25,593$91,879→ 383,495 total - Sale
COMMON STOCK, PAR VALUE $0.001
2017-12-13$3.57/sh−19,000$67,830→ 364,495 total - Award
COMMON STOCK, PAR VALUE $0.001
2017-11-29+150,000→ 409,088 total
Footnotes (2)
- [F1]Represents shares of common stock issued to the Reporting Person upon the partial vesting of an award of restricted stock units initially made on July 15, 2015.
- [F2]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on December 12, 2017, was $3.53 to $3.72, and the range of prices for the sale transactions on December 13, 2017, was $3.55 to $3.63. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001578699
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 8:18 PM ET
- Size
- 8.7 KB